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ORIGINAL CLINICAL RESEARCH
Cancers that are located in the thoracic inlet (TI)
frequently invade the subclavian artery (SA), the
subclavian vein (SV), and the brachial plexus.
Traditionally, surgical resection then is considered
hazardous or even contraindicated.1 We previously
described an original transcervical approach to the
resection of primary or secondary malignant diseases
that invade the TI.2,3 The purpose of this study was
to evaluate the technical aspects and the long-term
results of the resection and revascularization of the
SA invaded by TI cancers.
PATIENTS AND METHODS
Between July 1986 and April 1998, 128 patients
with TI cancers underwent evaluation at our institu-
tion. After an extensive preoperative workup, 15 of
these patients had an unresectable lesion and under-
went medical treatment. One patient was approached
surgically. The intraoperative histologic specimen
showed a small cell lung cancer histology, and the
operation therefore was abandoned. One hundred
and twelve patients underwent resection for TI can-
cer, and among them, 34 underwent resection for TI
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cancer that had invaded the SA. There were 25 men
and nine women, with a median age of 49 years
(range, 24 to 80 years). Twenty-eight patients (82%)
had a history of tobacco use. Twelve had aortoiliac
occlusive disease, and three had undergone a previous
aortoiliac reconstruction. The preoperative workup
consisted of venous angiography, aortic arch arteriog-
raphy, and duplex ultrasound scanning of the TI.
Local tumor invasion was evaluated with first rib
roentgenography and computed tomographic (CT)
scanning. In addition, head and neck and cervicotho-
racic magnetic resonance imaging (MRI) was per-
formed in 23 patients (68%).
Six patients underwent induction chemotherapy.
In three of these patients, radiation therapy was
added. Three patients previously had undergone an
unsuccessful surgical extirpation of the tumor.
Surgical technique. The details of the operative
technique have been described.2,3 A number of tech-
nical points are worth highlighting. Central venous
and arterial pressures were monitored. The patient
was placed in the supine position with the neck
hyperextended and the head turned away from the
involved side. The surgical approach was performed
through an L-shaped cervicotomy. The vertical arm
of the incision followed the anterior border of the
sternocleidomastoid muscle, and the horizontal arm
followed the lower border of the medial half of the
clavicle (Fig 1). The division of the sternal attach-
ment of the sternocleidomastoid muscle allowed
good exposure of the superior aspect of the subcla-
vian vessels and permitted assessment of the extend
and resectability of the tumor. The internal half of
the clavicle was removed when the tumor was
deemed resectable. The resection then was per-
formed in the following three steps: (1) dissection of
the veins, (2) dissection of the arteries, and (3) expo-
sure of the brachial plexus. The jugular and subcla-
vian veins were the most anterior elements in this
area. They were dissected, and their branches even-
tually were dissected. On the left side, ligation of the
thoracic duct usually was necessary. If the subclavian
or the innominate veins were involved with tumor,
they underwent resection after achieving proximal
and distal control and they did not undergo recon-
struction. The SA was dissected with a subadventitial
plane, but, when the arterial wall was involved with
tumor, its resection was necessary to obtain tumor-
free margins. Its distal part could be exposed after
division of the anterior scalenus muscle over the first
rib for tumor-free margins. The phrenic nerve was
identified and exposed on the anterior aspect of the
anterior scalene muscle (Fig 2). Depending on
whether or not the nerve was involved with tumor, it
was carefully preserved or resected. The division of
the branches of the invaded SA was simplified if prox-
imal control of its origin was obtained. The internal
mammary and the ascending cervical arteries were
divided. The vertebral artery underwent resection
only when it was involved or when the adjacent SA
was involved. Arterial reconstruction preferably was
performed with a direct end-to-end anastomosis.
This was often possible because the first rib always
was removed with the tumor. If the segment of artery
removed was too long and both ends were under
tension, a polytetrafluoroethylene (PTFE) ringed
graft (no. 6 or 8) was used as an interposition graft.
Extension of the tumor or compression of the
brachial plexus nerve branches necessitated an “out-
in side” dissection. Secondary branches and then pri-
mary branches of the brachial plexus were freed. The
lower trunk and eighth cervical and first thoracic
nerve roots could be dissected up to the spinal fora-
men. Although tumor that spread to the brachial
plexus could be high, neurolysis usually was achieved
without the need for the division of brachial plexus
branches above T1. Thereafter, exposure of the ver-
tebral body, the sympathetic chain, and the stellate
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Fig 1. Left L-shaped cervicotomy. Skin incision is made
from angle of mandible down to sternal notch after ante-
rior border of sternocleidomastoid muscle and is extended
horizontally under internal half of the clavicle as far as del-
topectoral groove.
ganglion was obtained easily, and tumor that had
spread to these structures could be easily resected.
Once the structures above the TI had been freed
from tumor and had been resected, the first and sec-
ond ribs or any adjacent structures, if involved, could
be easily resected.
A posterolateral thoracotomy can be associated
with the cervical approach for major pulmonary
resections. A posterior midline approach is added
when a vertebral resection is performed. Table I
shows the various histologic diagnoses.
Statistical analysis. All results are expressed as
the mean ± the standard error of the mean. The sur-
vival and patency rates were calculated by means of
life-table analysis. Kaplan-Meier method curves were
obtained. The patients were followed up with rou-
tine chest roentgenograms, computed tomographic
scans of the TI region, and duplex ultrasound scans
of the SA reconstruction. A subclavian arteriography
was performed when anomalies were reported on
duplex ultrasound scan. Sensitivity was calculated for
each study used to assess SA involvement with
tumor. These values were compared with the use of
the c 2 test. Differences were considered significant
at a P value of less than .05.
RESULTS
All the patients underwent en bloc removal of the
TI cancer with the invaded portion of the SA: 18 on
the right side, and 16 on the left side. An L-shaped
transclavicular cervicotomy was used in 33 patients.
In 14 of these patients, this approach was associated
with a one-stage posterolateral thoracotomy (n = 10)
or a posterior midline approach (n = 4). In one
patient with a proximally invaded left SA, the entire
procedure was performed through a single postero-
lateral thoracotomy. Eighteen lobectomies, one
pneumonectomy, and 11 wedge excisions were per-
formed. The first rib was removed in four patients,
the first and second ribs were removed in 18 patients,
the first, second, and third ribs were removed in 8
patients, and ribs 1 through 4 were resected in three
patients. Chest wall reconstruction was not per-
formed. In 24 patients (71%), the lower root (T1) of
the brachial plexus was involved with the tumor and
underwent resection. Among those patients, 10
required the removal of the phrenic nerve as well.
Four other patients underwent resection of the
phrenic nerve alone. In four patients, a sagittal T1-
to-T3 hemivertebrectomy and spinal reconstruction
was performed because of local invasion.
In addition to SA involvement, the SV was
involved with tumor in 10 patients, the vertebral
artery in three patients, the SV and the vertebral
artery in six patients, and the SV and the right bra-
chiocephalic vein in one patient. The operative strat-
egy used here was complete vascular resection and
reconstruction of the SA alone. In two patients, the
innominate artery and the right brachiocephalic vein
were invaded. Resection was followed by arterial
reconstruction with a PTFE tubular ringed graft (8
mm) in one patient and by an end-to-end anasto-
mosis in the other patient between the proximal
innominate artery and the SA—the right carotid
artery was transposed into the graft or the SA in an
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Table I. Histologic findings
Histology No. of patients
Non–small cell lung cancer 29
Thyroid carcinoma metastasis 1
Osteosarcoma of first rib 1
Fibrosarcoma 1
Ewing’s sarcoma of first rib 1
Adenocarcinoma of unknown origin 1
Fig 2. Invaded left subclavian artery is exposed after divi-
sion of anterior scalenus muscle over first rib in tumor-free
margins. It then is divided proximally and distally.
end-to-side fashion. The SA was the sole vessel
invaded in 12 patients.
In the remaining 32 cases of SA revascularization,
a primary end-to-end anastomosis was performed in
16 patients. In one patient, a subclavian-left common
carotid artery transposition was performed. In 15
patients, a prosthetic graft (6-mm PTFE, n = 5; 8-
mm PTFE, n = 10) was used. The PTFE graft was
ringed in all but one instance during the earlier part
of the series. The mean length of the PTFE grafts was
2.5 ± 0.6 cm (range, 1.5 to 4 cm). No temporary
arterial shunt was used. The arterial reconstruction
was not shielded from the remaining lung. 
In two patients, the tumor had to be left behind
within the brachial plexus. Postoperative radiation
therapy ranging from a total dose of 30 to 60 Gy was
used in 33 patients (97%), and postoperative
chemotherapy of two to five cycles in 25 was used in
patients (74%).
Frozen sections of pathologic specimens always
were obtained during the operation on the distal
margins of the tumor-bearing areas but not system-
atically on the SA. Permanent pathologic sections
showed tumor invasion of the SA sheath in 30
patients (80%), and cancerous cells were present in
the adventitia in 26 cases and in the media in four
cases. Four patients had tumors that abutted and
surrounded the artery on permanent section, with-
out a clear margin but without arterial wall invasion. 
Table II shows the results of the preoperative
studies used to assess SA involvement with tumor.
The study results were considered positive only if
they showed a clear loss of tissue planes with com-
puted tomographic (CT) scanning (Fig 3) or with
magnetic resonance imaging (MRI) and vessel wall
changes with arteriography (Fig 4) or venography.
CT scanning and MRI results were more sensitive to
predict tumor involvement of the SA than were arte-
riography (P < .05) and duplex scanning (P <
.0001). Venography results showed tumor involve-
ment of the SV in 15 SVs (83%) among the 18 SVs
invaded.
There were no perioperative deaths, neurologic
sequelae (except those caused by nerve resection),
graft infections, graft occlusions, or limb ischemia.
Five patients (15%) were seen with a perioperative
complication: a lateral tracheal wall necrosis that
resolved spontaneously was observed in one patient.
Prolonged ventilatory support (7 and 11 days) was
necessary in two patients in whom extended chest
wall and phrenic nerve resections had been done.
One patient was seen with a cerebrospinal fluid leak
after spinal resection. A ventriculo-peritoneal shunt
was performed. A peptic ulcer developed in one
patient and was successfully treated with antihista-
minic drugs. 
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Fig 3. Computed tomographic scan results show 4-cm right non–small cell lung cancer invad-
ing thoracic inlet. Tumor is adherent to subclavian artery with clear loss of tissue planes.
Table II. Results of preoperative studies in pre-
dicting subclavian artery involvement with tumor
No. of arteries
Preoperative test No. of patients involved Sensitivity (%)
Arteriography 34 20 59
Duplex scanning 34 5 15
CT scanning 34 28 82
MRI 23 19 83
CT, Computed tomography; MRI, magnetic resonance imaging.
Postoperative follow-up was performed at 3-
month intervals for 12 months and at 6-month inter-
vals thereafter. Assessment included clinical examina-
tion and bilateral arm blood pressure measurements
and pulses. A duplex scan was performed at 3 and 6
months after surgery and annually thereafter. Graft
patency was defined with direct color duplex imaging
or with evidence of restored ipsilateral arm hemody-
namics as manifested by the presence of palpable
pulses, absence of pressure gradients, and freedom
from clinical symptoms. Angiographic assessment
was performed in patients in whom duplex scanning
results indicated stenosis of ‡ 80% and in patients with
symptoms of stenosis. No patient was lost to follow-
up examination. 
There were two delayed asymptomatic PTFE
graft occlusions. The patient who underwent revas-
cularization with a nonringed PTFE graft had a late
occlusion at 12 months with a concomitant throm-
bosis of the SV. The other patient had a 8-mm
ringed PTFE graft and was seen with an occlusion at
31 months. Angiographic control showed extensive
collaterals in both cases. These delayed asympto-
matic graft occlusions could be related to radiation-
induced local fibrosis. The 5-year patency rate was
85% (Fig 5).
During this study, 20 patients (59%) died—18 of
tumor recurrence (5 local and systemic; 13 sys-
temic), one of respiratory failure, and one of an
unknown cause at 74 months. With a median fol-
low-up period of 2.1 years, the overall 5-year sur-
vival rate was 36% (Fig 6).
Fourteen patients (41%) were alive at 2 to 143
months. Two patients were seen with a local recur-
rence at 17 and 19 months. They underwent treat-
ment with chemotherapy and radiation therapy.
Another four patients were seen with a metastatic
recurrence: a controlateral pulmonary metastasis was
present in two patients at 19 and 20 months and was
treated with chemotherapy alone; an adrenal metas-
tasis was present at 19 months in one patient and
was treated with chemotherapy and radiation thera-
py; and a cerebral metastasis was seen at 20 months
in one patient and was successfully resected. This last
patient was alive 2 years after the metastasectomy
without recurrence. Another type of lung cancer
developed in one patient at 130 months. Seven
patients were alive and free of carcinoma. The over-
all 5-year disease-free survival rate was 18% (Fig 7).
DISCUSSION
This study provides definitive evidence that the
resection and revascularization of subclavian arteries
invaded by malignant diseases is technically feasible
and is associated with low surgical morbidity and
mortality rates and encouraging long-term results in
term of patency and survival rates as well. 
TI cancers are characterized by local aggressive-
ness, a tendency to encapsulate neighboring struc-
tures, high postoperative recurrence rates, and, in
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Fig 4. Arteriogram showing stenosis of right subclavian
artery beyond origin of vertebral artery. This lesion is
caused by arterial wall invasion by right lung cancer locat-
ed in thoracic inlet.
Fig 5. Life-table analysis graph of subclavian artery revas-
cularization patency rates. Vertical bars indicate standard
errors.
some cases, a propensity to metastasize.4,5 Patients
who are affected are usually highly symptomatic
with a shortened survival rate. Surgical management
of these tumors should be aimed at relieving the
symptoms while minimizing the risk of local recur-
rence through a radical operation. No other avail-
able treatment option offers equivalent chances for
cure or palliation. Chemotherapy alone is not indi-
cated as a curative treatment for TI cancers.6 With
radiotherapy alone, the overall 5-year survival rates
of TI cancers range from 0 to 29%.6 Therefore, a
low-risk surgical procedure is rationally sound.
Surgical experience with malignant diseases that
involve the TI has long been limited to superior sul-
cus tumors,7 and neoplastic involvement of the sub-
clavian vessel or brachial plexus was considered a
contraindication to any surgical approach because of
the dismal outcome and high cost/benefit ratio. The
absolute surgical contraindications in the manage-
ment of TI cancers are the presence of extrathoracic
sites of metastasis, histologically confirmed mediasti-
nal lymph node invasion disease, and the extensive
invasion of the cervical trachea, the esophagus, the
vertebral body, and the brachial plexus above the C7
nerve root.
Because of the high density and tumor volume,
color duplex scanning cannot predict tumor invasion
of the SA. This method was able to predict SA inva-
sion in only 15% of the cases. Similarly, angiograms
were able to predict invasion in only 59% of the cases.
This correlates with other studies on the predictive
value of these two methods.8 In fact, the angiogram
is an important portion of the preoperative work-up
because it provides delineation of the TI vascular
anatomy, which allows for a more precise planning of
the type of revascularization. CT scanning was help-
ful in assessing the extent of chest wall and vertebral
body involvement and in ruling out mediastinal
nodal disease. In all cases in which CT scans or MRIs
were obtained, it was particularly predictive of SA
invasion, mainly on the basis of the lack of a clear
plane between the vessel and the tumor (Fig 3). This
contradicts the findings of Wright et al9 and is possi-
bly a result of the improved quality of recent CT
scanning machines. Because of the multiple overlying
structures at the apex of the chest, CT scanning gives
the surgeon the best estimate of the extent of the
lesion10,11 and probably allows for more a accurate
prediction regarding the ability to do a radical resec-
tion. The use of magnetic resonance imaging, which
provides direct coronal and sagittal sections, is of
additional benefit. In our experience, it is also of par-
ticular value in showing arterial invasion.
In contrast with the low sensitivity of the invasive
studies in showing arterial invasion, venograms were
able to predict SV invasion in 83% of the cases. This
method is also important to rule out an invasion of
the superior cava vein, which would necessitate the
interposition of prosthetic material after resection.12
A number of surgical approaches to TI cancer have
already been reported.1,7,13 None allow the safe expo-
sure of the tumor, brachial plexus, or subclavian ves-
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Fig 6. Life-table analysis graph of survival rates for tho-
racic inlet cancers invading subclavian artery resection.
Vertical bars indicate standard errors.
Fig 7. Life-table analysis graph of disease-free survival
rates for thoracic inlet cancers invading subclavian artery
resection. Vertical bars indicate standard errors.
sels. The transclavicular approach that was described
previously2,3 provides a good exposure of the entire
TI, which allows safe dissection, complete surgical
clearance of the primary tumor, and subclavian vessel
dissection. In a previous study on 55 patients with
non–small cell lung cancer invading the TI who under-
went operation in our institution, there was no signif-
icant difference in the overall survival rates between
patients with and without SA invasion.14 Other stud-
ies15,16 have provided definitive evidence that only
complete resection provides long-term survival and
cure in selected cases. Once the tumor and the invad-
ed portion of the SA are resected, the SA is systemati-
cally reconstructed. Ligation of this artery alone with-
out revascularization uniformly results in fatal ischemia
of the upper limb, as described by Paulson7 and
Wright et al.9 This can be explained by the necessary
interruption of the collateral circulation to the arm
during the dissection. On the other hand, the ligation
of the vertebral artery alone without bypass grafting
did not result in neurologic complications when no
cerebrovascular disease was present. Similarly, because
of their rich collateral circulations, the subclavian and
internal jugular veins generally are simply ligated after
the resection of the involved segments.
Most of the PTFE grafts in this series were inter-
posed in the begining of the experience. The late
occlusion of two PTFE grafts and the observation
that, because the first rib is always resected, an end-
to-end anastomosis of both SA stumps is almost
always possible because of gained length, result in a
decrease in PTFE graft use. Only when the arterial
resection is too extensive would we interpose a PTFE
graft. PTFE is preferred because nearly all the
patients undergo postoperative radiation therapy to
the TI (30 to 60 Gy). Radiation therapy results in
localized fibrotic changes of the TI soft tissues.7
PTFE grafts have a good long-term patency rate in
postradiation specimens12 and in carotid-axillary
artery bypass grafting.17 Dacron grafting had been
used in SA reconstruction after such a resection in
two cases by Fukuse et al,15 but the long-term paten-
cy rate of this graft was not completely reported. We
prefer the ringed PTFE grafts (6-mm or 8-mm)
because they are more resistant to fibrosis. In carotid-
subclavian bypass grafting for SA occlusive disease,
Ziomek et al18 found a significant superiority of
PTFE or Dacron grafts over autologous veins. They
explain that the multiaxial mobility of the neck might
have caused kinking and shortening of the graft. In
this series, only two patients had delayed asympto-
matic PTFE graft occlusion and the overall 5-year
patency rate was 85%. The patient whose revascular-
ization was performed with a nonringed PTFE graft
had a late occlusion at 12 months, and another
patient with a 8-mm ringed PTFE graft was seen at
31 months with an occlusion. In both cases, angio-
graphic control showed extensive collateral circula-
tion from the external carotid and internal thoracic
arteries to the arm, which explains the lack of clinical
upper limb ischemia. None of the patients with a
direct end-to-end anastomosis had an occlusion.
The results from this series support the fact that
clinical outcome and patency rates after SA replace-
ment for TI cancers are acceptable, as supported by
the 5-year and 10-year patency rates of 85%. Despite
the fact that postoperative radiation therapy was used
extensively, these results are comparable with those
obtained after SA revascularization for atheromatous
occlusive lesions of the proximal SA. Patency rates of
66% to 89% are reported for axilloaxillary bypass graft-
ing19-21 and 83% to 96% for carotid-axillary bypass
grafting.17,22,23 Although carotid-subclavian transpo-
sition has been reported to have a better patency
rate,24 it is usually not possible after TI cancer resec-
tion because the SA is resected distally. Even when
there is gain of length after rib resection, the excess
length is at the proximal portion of the artery. In this
group of patients, there was no role for percutaneous
transluminal angioplasty, despite the good patency
rates that were obtained with this procedure.25
In conclusion, tumor arterial invasion per se
should not be a contraindication to TI cancer resec-
tion. Similar to what has been shown with tumors that
invade carotid arteries,8,26,27 this study shows that
cancers that invade the SA can be resected with good
results with a concomitant revascularization of the SA.
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